| Debra Sue White, FNP | |
|
800 W 9th St, Jasper, IN 47546-2514 | |
| (812) 996-0323 | |
| (812) 996-0321 |
| Full Name | Debra Sue White |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 10 Years |
| Location | 800 W 9th St, Jasper, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811392129 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 28090769A (Indiana) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 28090769 (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hospital And Health Care Center | Jasper, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Little Company Of Mary Hospital Of Indiana Inc | 4587578042 | 167 |
News Archive
Neuromuscular experts with the University of Miami Health System and the Miller School of Medicine will launch a Phase 1/2 clinical trial (NCT04146051) using the CAR-T drug, Descartes-08, to treat patients with generalized myasthenia gravis.
Immunosuppressive regulatory T-cells play an important role in the functioning of adipose tissue. This is the discovery of scientists from the Helmholtz Diabetes Center at Helmholtz Zentrum München and the Technical University of Munich.
The world's first mapping of an entire country's chronic diseases shows that approximately two out of three Danes over the age of 16 have one or more chronic conditions. This is nearly twice the previous estimates from Danish authorities.
Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated two of the company's Phase 3 antibiotic candidates, CXA-201 (ceftolozane/tazobactam) and CB-315, as Qualified Infectious Disease Products (QIDP).
VIVUS, Inc. today announced that it has closed the sale of its MUSE business to Meda. Under the purchase agreement, Meda acquired the MUSE assets including the United States and foreign MUSE patents, existing inventory and the manufacturing facility located in Lakewood, New Jersey.
› Verified 1 days ago
| Entity Name | Little Company Of Mary Hospital Of Indiana Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114120128 PECOS PAC ID: 4587578042 Enrollment ID: O20031118000733 |
News Archive
Neuromuscular experts with the University of Miami Health System and the Miller School of Medicine will launch a Phase 1/2 clinical trial (NCT04146051) using the CAR-T drug, Descartes-08, to treat patients with generalized myasthenia gravis.
Immunosuppressive regulatory T-cells play an important role in the functioning of adipose tissue. This is the discovery of scientists from the Helmholtz Diabetes Center at Helmholtz Zentrum München and the Technical University of Munich.
The world's first mapping of an entire country's chronic diseases shows that approximately two out of three Danes over the age of 16 have one or more chronic conditions. This is nearly twice the previous estimates from Danish authorities.
Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated two of the company's Phase 3 antibiotic candidates, CXA-201 (ceftolozane/tazobactam) and CB-315, as Qualified Infectious Disease Products (QIDP).
VIVUS, Inc. today announced that it has closed the sale of its MUSE business to Meda. Under the purchase agreement, Meda acquired the MUSE assets including the United States and foreign MUSE patents, existing inventory and the manufacturing facility located in Lakewood, New Jersey.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Debra Sue White, FNP 6493 E Freelandville Rd, Oaktown, IN 47561-8204 Ph: (812) 887-3546 | Debra Sue White, FNP 800 W 9th St, Jasper, IN 47546-2514 Ph: (812) 996-0323 |
News Archive
Neuromuscular experts with the University of Miami Health System and the Miller School of Medicine will launch a Phase 1/2 clinical trial (NCT04146051) using the CAR-T drug, Descartes-08, to treat patients with generalized myasthenia gravis.
Immunosuppressive regulatory T-cells play an important role in the functioning of adipose tissue. This is the discovery of scientists from the Helmholtz Diabetes Center at Helmholtz Zentrum München and the Technical University of Munich.
The world's first mapping of an entire country's chronic diseases shows that approximately two out of three Danes over the age of 16 have one or more chronic conditions. This is nearly twice the previous estimates from Danish authorities.
Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated two of the company's Phase 3 antibiotic candidates, CXA-201 (ceftolozane/tazobactam) and CB-315, as Qualified Infectious Disease Products (QIDP).
VIVUS, Inc. today announced that it has closed the sale of its MUSE business to Meda. Under the purchase agreement, Meda acquired the MUSE assets including the United States and foreign MUSE patents, existing inventory and the manufacturing facility located in Lakewood, New Jersey.
› Verified 1 days ago